Found: 1
Select item for more details and to access through your institution.
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS)
- Published in:
- British Journal of Dermatology, 2024, v. 191, n. 1, p. 36, doi. 10.1093/bjd/ljad523
- By:
- Publication type:
- Article